Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1929)	2/26/2008 10:51:28 AM
From: Jibacoa	Read Replies (1) of 3722

CALP has continued to try finding support above the $4 level.<g> Today it is down 6.58% on moderate volume of 18,542 about 0.2x its ADV bigcharts.marketwatch.com It announced today that it entered into an agreement with AntiCancer to establish a cross-licensing relationship and end all outstanding patent litigation. CALP will acquire the right to sublicense AntiCancer's fluorescent protein optical imaging patents to third-parties, & AntiCancer will acquire the right to sublicense Caliper's optical imaging patents, in the field of fluorescent protein imaging. As previously mentioned, CALP has 4Qs of double digit improvements on revenues & on the 3rdQ (Sep) it reported on the black $0.03 vs. the loss of $0.16 in 2006. The loss for 2007 is expected around $0.14/shr vs. $0.26 in 2006 The stock trades around 1.4xBV with little LTD & has now small +CF in spite of its long Hx of losses. The insiders hold > 10% & institutions around 30%. It seems that the R/R isn't bad at present levels. The March 2002 H was $202 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next